Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to -$279000.0.

  • Arcadia Biosciences' Free Cash Flow rose 8407.53% to -$279000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.1 million, marking a year-over-year increase of 4750.11%. This contributed to the annual value of -$9.6 million for FY2024, which is 3717.09% up from last year.
  • Latest data reveals that Arcadia Biosciences reported Free Cash Flow of -$279000.0 as of Q3 2025, which was up 8407.53% from -$2.0 million recorded in Q2 2025.
  • Arcadia Biosciences' Free Cash Flow's 5-year high stood at -$279000.0 during Q3 2025, with a 5-year trough of -$8.5 million in Q3 2021.
  • Moreover, its 5-year median value for Free Cash Flow was -$3.4 million (2022), whereas its average is -$3.7 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first crashed by 7259.88% in 2023, then skyrocketed by 8407.53% in 2025.
  • Quarter analysis of 5 years shows Arcadia Biosciences' Free Cash Flow stood at -$6.8 million in 2021, then surged by 64.53% to -$2.4 million in 2022, then tumbled by 72.6% to -$4.2 million in 2023, then surged by 47.43% to -$2.2 million in 2024, then soared by 87.21% to -$279000.0 in 2025.
  • Its Free Cash Flow was -$279000.0 in Q3 2025, compared to -$2.0 million in Q2 2025 and -$1.6 million in Q1 2025.